High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumannii: An Observational Cohort Study

Hui Han, Weidong Qin, Yue Zheng, Dongming Cao, Haining Lu, Lu Zhang, Yi Cui, Yuanyuan Hu, Wei Li, Haipeng Guo,

Infection and Drug Resistance · 2021 · 16 citations · 24 references

DOIFull text

Open access

Abstract

A tigecycline dose that is twice its standard dose is better for the treatment of XDR-AB infection only in BSI associated with non-pulmonary infection.

References

24